October 9, 2013
CME-Certified Cancer Immunotherapy Program
for Oncologists Coming to Pittsburgh!
Program topics include:
- Adoptive Transfer
- Cytokines
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors
- Immunology for the Non-immunologist: Measuring Immune Response
- Immunotherapy Combinations with Small Molecules, Surgery and Radiation
- Ipilimumab: Combinations and Future Directions
- Microenvironment and Immune Suppression
- Therapy of Cancer with PD-1 Antibody and Combination
- Tumor Antigen Targeted Monoclonal Antibodies and Combinations in the Clinic
- Vaccines
This program also includes a continental breakfast, panel discussions, and ARS assisted audience interaction. Registration for SITC members in the clinician/academic or government classification is only $50. SITC members who are students and allied health professionals should contact SITC for reduced rates.
A special reception in honor of Ronald B. Herberman, MD will follow beginning at 4 p.m.
Early Registration Now Available!
.jpg){kind=small}
More information will be announced soon! For full accreditation information, visit: www.sitcancer.org/sitc-meetings/aci2013/pa.
Jointly-Sponsored by Postgraduate Institute for Medicine and Society for Immunotherapy of Cancer
.jpg) |
|
In collaboration with UPMC
.jpg)
The Advances in Cancer Immunotherapy series is supported in part by:
- Bristol-Myers Squibb
- Merck
- Prometheus
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Full disclosure of support will be made in the course materials.
